Healius Ltd
ASX:HLS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Healius Ltd
ASX:HLS
|
AU |
|
Gujarat Fluorochemicals Ltd
NSE:FLUOROCHEM
|
IN |
|
Integral Diagnostics Ltd
ASX:IDX
|
AU |
|
Australian Clinical Labs Ltd
ASX:ACL
|
AU |
Wall Street
Price Targets
HLS Price Targets Summary
Healius Ltd
According to Wall Street analysts, the average 1-year price target for HLS is 0.73 AUD with a low forecast of 0.58 AUD and a high forecast of 0.85 AUD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HLS's stock price target?
Price Target
0.73
AUD
According to Wall Street analysts, the average 1-year price target for HLS is 0.73 AUD with a low forecast of 0.58 AUD and a high forecast of 0.85 AUD.
What is Healius Ltd's Revenue forecast?
Projected CAGR
5%
For the last 13 years the compound annual growth rate for Healius Ltd's revenue is 0%. The projected CAGR for the next 3 years is 5%.
What is Healius Ltd's Operating Income forecast?
Projected CAGR
643%
For the last 13 years the compound annual growth rate for Healius Ltd's operating income is -42%. The projected CAGR for the next 3 years is 643%.
